EMA Authorised: Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) (clopidogrel;acetylsalicylic acid) — Sanofi-Aventis Groupe

View source ↗

Summary

European Medicines Agency authorised a clopidogrel and acetylsalicylic acid combination product (Zentiva/DuoCover) for acute coronary syndrome and myocardial in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Clopidogrel/Acetylsalicylic acid (DuoCover) (clopidogrel; acetylsalicylic acid)
• Clopidogrel/Acetylsalicylic acid Zentiva (clopidogrel; acetylsalicylic acid)

Snippet

Status: Authorised. Therapeutic area: Acute Coronary Syndrome;Myocardial Infarction. MAH: Sanofi-Aventis Groupe. Decision date: 19/09/2019